Symbol Name ID |
Cxcr4
C-X-C motif chemokine receptor 4 MGI:109563 |
Darker colors indicate more annotations |
Human Phenotypes | Decreased circulating IgG level |
Monoclonal immunoglobulin M proteinemia |
Polyclonal elevation of IgM |
Decreased circulating antibody level |
Neutropenia |
Impaired lymphocyte transformation with phytohemagglutinin |
Abnormality of neutrophils |
Leukemia |
Acute myeloid leukemia |
Recurrent upper respiratory tract infections |
Lymphadenopathy |
Splenomegaly |
Cryoglobulinemia |
Recurrent infections |
Recurrent bacterial infections |
Disease(s) Associated with CXCR4 | |||||||||||||||
acute myeloid leukemia | |||||||||||||||
lymphoplasmacytic lymphoma | |||||||||||||||
WHIM syndrome |
Mouse Phenotypes | decreased B cell apoptosis |
abnormal leukocyte migration |
abnormal thymus morphology |
decreased thymocyte number |
enlarged spleen |
abnormal leukopoiesis |
abnormal lymphopoiesis |
abnormal B cell differentiation |
decreased immature B cell number |
decreased pro-B cell number |
abnormal T cell differentiation |
decreased double-positive T cell number |
failure of myelopoiesis |
impaired myelopoiesis |
increased neutrophil cell number |
abnormal neutrophil morphology |
decreased mature B cell number |
decreased B-1 B cell number |
decreased B-2 B cell number |
decreased plasma cell number |
increased mature B cell number |
decreased B cell number |
decreased NK cell number |
increased NK cell number |
abnormal CD4-positive, alpha-beta T cell number |
decreased CD4-positive, alpha-beta T cell number |
increased CD8-positive, alpha-beta T cell number |
decreased T cell number |
increased lymphocyte cell number |
abnormal macrophage cell number |
increased monocyte cell number |
decreased leukocyte cell number |
increased leukocyte cell number |
abnormal spleen morphology |
decreased spleen weight |
abnormal spleen white pulp morphology |
abnormal B cell physiology |
increased IgG level |
increased IgM level |
decreased immunoglobulin level |
increased immunoglobulin level |
abnormal NK cell physiology |
abnormal immune system morphology |
abnormal immune system cell morphology |
abnormal immune system organ morphology |
abnormal Peyer's patch follicle morphology |
abnormal lymph node morphology |
abnormal lymph node B cell domain morphology |
abnormal immune system physiology |
decreased susceptibility to induced arthritis |
increased susceptibility to Retroviridae infection induced morbidity/mortality |
decreased susceptibility to Retroviridae infection |
|
Availability | Mouse Genotype | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Cxcr4tm1Qma/Cxcr4tm1Qma | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Cxcr4tm1Tng/Cxcr4tm1Tng | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Cxcr4tm1Yzo/Cxcr4tm1Yzo | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Cxcr4tm3.1Yzo/Cxcr4tm3.1Yzo | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Cxcr4em1(IMPC)Mbp/Cxcr4+ | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Cxcr4tm1.1Bala/Cxcr4+ | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Cxcr4tm1Yiw/Cxcr4tm1Yiw Tg(Lck-cre)1Jtak/0 (conditional) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Cxcr4tm2Yzo/Cxcr4tm2Yzo Cd19tm1(cre)Cgn/Cd19+ (conditional) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Cxcr4tm2Yzo/Cxcr4tm2Yzo Lyz2tm1(cre)Ifo/Lyz2+ (conditional) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Cxcr4tm2Yzo/Cxcr4tm2Yzo Tg(Fabp4-cre)1Rev/0 (conditional) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Cd19tm1(cre)Cgn/Cd19+ Cxcr4tm1Tng/Cxcr4tm2Tng (conditional) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Cxcr4tm2Yzo/Cxcr4tm3.1Yzo Cd19tm1(cre)Cgn/Cd19+ (conditional) |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|